Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

44 ta ish

Ish: Evaluation of Antifibrotic Activity of a Combination of a New Phytocomposition and Proanthocyanidins in Rats.

  1. Proteins from the Aerial Part of Delphinium leptocarpum and Their Biological Activity

    Sh. Kh. Rakhimova, U. Kh. Kurbanov, L. G. Mezhlumyan +4

    MaqolaPlant-based Medicinal ResearchChemistry of Natural Compounds20234 iqtibos
    ABI

  2. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

    Ali A. Mokdad, Alan D López, Saied Shahraz +5

    Maqola20144 iqtibos
    ABI

  3. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety

    Martins Ekor

    Sharh maqola20144 iqtibos
    ABI

  4. CHEMICAL COMPOSITION AND BIOLOGICAL ACTIVITY OF METABOLITES OF THE GENUS ALHAGI

    S. Z. Nishanbaev, Il'dar Dzhamil'yevich Sham’yanov, Khayrulla Bobakulov +1

    Maqola20194 iqtibos
    ABI

  5. Neutral substances from Alhagi pseudalhagi

    Н. М. Маматкулова, D. F. Alimova, S. Z. Nishanbaev +2

    MaqolaGarlic and Onion StudiesChemistry of Natural Compounds20123 iqtibos
    ABI

  6. Hepatoprotective Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, and Lycopene in Experimental Chronic Hepatitis Compared to Phosphogliv

    В. Н. Сыров, S. D. Gusakova, З. А. Хушбактова +3

    MaqolaPharmacological Effects of Natural CompoundsPharmaceutical Chemistry Journal20233 iqtibos
    ABI

  7. Antifibrotic Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, Lycopene and Proanthacyanidin in Experimental Severe Chronic Hepatitis Compared with Phosphogliv

    A. N. Aripov, L. L. Akhunzhanova, A. U. Nabiev +2

    MaqolaPharmacological Effects of Natural CompoundsBiomedical & Pharmacology Journal20233 iqtibos
    ABI

  8. Global epidemiology of cirrhosis — aetiology, trends and predictions

    Daniel Q. Huang, Norah A. Terrault, Frank Tacke +4

    Sharh maqola20233 iqtibos
    ABI

  9. Liver fibrosis and repair: immune regulation of wound healing in a solid organ

    Antonella Pellicoro, Prakash Ramachandran, John P. Iredale +1

    Sharh maqola20143 iqtibos
    ABI

  10. AASLD guidelines for the treatment of hepatocellular carcinoma

    Julie K. Heimbach, Laura Kulik, Richard S. Finn +6

    Maqola20172 iqtibos
    ABI

  11. Liver cirrhosis

    Pere Ginès, Aleksander Krag, Juan G Abraldes +3

    Maqola20212 iqtibos
    ABI

  12. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

    Gennaro D’Amico, Guadalupe García–Tsao, Luigi Pagliaro

    Sharh maqola20052 iqtibos
    ABI

  13. Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

    Jürg Reichen, Bernhard Egger, N. Ohara +3

    Maqola19882 iqtibos
    ABI

  14. CYTOKINE PROFILE OF RAT BLOOD IN EXPERIMENTAL PERIODONTIS AND EFFECT OF IMMUNE MODULATORS

    Evgeniy Mokrenko, A.Y. Vyazmin, Петр Д. Шабанов +3

    Maqola20202 iqtibos
    ABI

  15. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Maqola20222 iqtibos
    ABI

  16. rgho: Access WHO Global Health Observatory Data from R

    Kevin Zarca, Antoine Filipović-Pierucci

    Boshqa20162 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI